跳至主要内容
临床试验/CTRI/2024/07/071727
CTRI/2024/07/071727尚未招募3 期

A randomized open labelled single arm clinical study of Ashwattha pallava churna in Medoroga with special reference to Dyslipidemia

Dr. Sahil Bhavsar1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年8月20日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Lipid profile

研究概览

简要总结

This study is randomized, open labelled, single arm clinical study evaluating the safety and efficacy of Ashwattha Pallava Churna (Ficus religiosa Linn.) 5 gm BID for 60 days in 40 randomly selected patients from the hospital of Taranath Goverrnment Ayurvedic Medical College and Hospital Ballari, Karnataka.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • BMI between 25 to 38.9 kg/m2 .
  • Dyslipidemia associated disorders like Non-insulin dependent diabetes mellitus [NIDDM]- RBS up to 200 mg/dl.
  • Coronary artery disease [CAD] P/H/O myocardial infarction Hypertension B.P. up to 160/100 mmHg.

排除标准

  • Patients with HIV, HbsAg or any infective disorders 2) Patients undergone cardiac surgeries like coronary artery bypass graft [CABG], angioplasty, open heart surgery etc.
  • BMI less than 24 kg/m2 and more than 39 kg/m2 .
  • Chronic severe disorders like Chronic renal failure.
  • Severe type 2 diabetes mellitus- RBS more than 200mg/dl.
  • Severe hypertension – more than 160/100 mmHg.

结局指标

主要结局

Lipid profile

时间窗: 3 months

次要结局

  • All outcomes which effect the quality of life.(6 months)

研究者

发起方
Dr. Sahil Bhavsar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Sahil Bhavsar

Taranath Government Ayurvedic Medical College

研究点 (1)

Loading locations...

相似试验